Persistence of essential FAtty acid deficiency in cystic fibrosis despite nutritional therapy

Pediatric Research

Volumn 66, Issue 5, 2009, Pages 585-589

  Aldámiz ECHEVARRÍA, Luis ^a   José, Angel Prieto ^a   Fernando, Andrade ^a   Javier, Elorz ^a   Amaia, Sojo ^a   Sergio, Lage ^a   Pablo, Sanjurjo ^a   Carlos, Vázquez And ^a   Juan, Rodríguez Soriano ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ALPHA TOCOPHEROL; COLECALCIFEROL; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; LIGNOCERIC ACID; LINOLEIC ACID; OLEIC ACID; PHYTOMENADIONE; RETINOL ACETATE;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIET THERAPY; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LIVER DISEASE; LUNG DISEASE; LUNG FUNCTION; MALE; NUTRITIONAL STATUS; PANCREAS FUNCTION; PRIORITY JOURNAL; SCHOOL CHILD;

AGE FACTORS; ANTHROPOMETRY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FATTY ACIDS; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIVER DISEASES; MALE; NUTRITION THERAPY; PANCREAS; TIME FACTORS;

EID: 73249123043     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181b4e8d3     Document Type: Article

References (43)

1. Kulczycki LL, Kostuch M, Bellanti JA 2003 A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations. Am J Med Genet 116:262-267 (Pubitemid 36056745)
2. Steinkamp G, Wiedemann B 2002 Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 57:596-601 (Pubitemid 34761761)
3. Gibson RA, Teubner JK, Haines K, Cooper DM, Davidson GP 1986 Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 5:408-415 (Pubitemid 17003272)
4. Farrell PM, Mischler EH, Engle MJ, Brown J, Lau SM 1985 Fatty acid abnormalities in cystic fibrosis. Pediatr Res 19:104-109 (Pubitemid 15187486)
5. Lloyd-Still JD, Bibus DM, Powers CA, Johnson SB, Holman RT 1996 Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. Acta Paediatr 85:1426-1432
6. Cristophe A, Robberecht E 1996 Current knowledge on fatty acids in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 55:129-138 (Pubitemid 26366828)
7. Roulet M, Frascarolo P, Rappaz I, Pilet M 1997 Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 156:952-956 (Pubitemid 28006316)
8. Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlström J 2001 Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 139:650-655 (Pubitemid 33097428)
9. Colombo C, Bennato V, Costantini D, Valmarana L, Daccò V, Zazzeron L, Ghisleni D, Bruzzese MG. Scaglioni S, Riva E, Agostoni C 2006 Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: are they related to clinical outcomes? J Pediatr Gastroenterol Nutr 43:660-664
10. Dombrowsky H, Clark GT, Rau GA, Bernhard W, Postle AD 2003 Molecular species compositions of lung and pancreas phospholipids in the CFTRtmlHGU/ tmlHGU cystic fibrosis mouse. Pediatr Res 53:447-454 (Pubitemid 36237400)
11. Werner A, Bongers ME, Bijvelds MJ, de Jonghe HR, Verkade HJ 2004 No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. J Lipid Res 45:2277-2286 (Pubitemid 39602975)
12. Van Biervliet S, Vanbillemont G, Van Biervliet JP, Declercq D, Robberecht E, Christophe A 2007 Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients. Ann Nutr Metab 51:541-549 (Pubitemid 351315920)
13. Coste TC, Deumer G, Reychler G, Lebecque P, Wallemacq P, Leal T 2008 Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis. Clin Chem 54:388-395 (Pubitemid 351302637)
14. Rosenstein BJ, Cutting GR 1998 The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:589-595
15. Kalnins D, Durie PR, Pencharz P 2007 Nutritional management of cystic fibrosis patients. Curr Opin Clin Nutr Metab Care 10:348-354 (Pubitemid 46596713)
16. Hernández M, Castellet J, Narvaiza JL, Rincón JM, Ruiz I, Sánchez E, Sobradillo B, Zurimendi A 1988 Curvas y tablas de crecimiento. Instituto sobre crecimiento y desarrollo. Ed Garsi, Madrid, pp 1463-1465
17. Mayer OH, Jawad AF, McDonough J, Allen J 2008 Lung function in 3-5-year-old children with cystic fibrosis. Pediatr Pulmonol 43:1214-1223
18. Walkowiak J, Nousia-Arvanitakis S, Cade A, Kashirskaya N, Piotrowski R, Strzykala K, Kouniou M, Pogorzelski A, Sands D, Kapranov N 2002 Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis. J Cyst Fibros 1:260-264
19. Williams SG, Evanson JE, Barrett N, Hodson ME, Boultbee JE, Westaby D 1995 An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. J Hepatol 22:513-521
20. Lepage G, Roy CC 1986 Direct transesterification of all classes of lipids in one step reaction. J Lipid Res 27:114-120 (Pubitemid 16045295)
21. Batal I, Ericsoussi MB, Cluette-Broen JE, O'Sullivan BP, Freedman SD, Savaille JE, Laposata M 2007 Potential utility of plasma fatty acids analysis in the diagnosis of cystic fibrosis. Clin Chem 53:78-84 (Pubitemid 46047765)
22. Holman RT 1960 The ratio of trienoic: tetraenoic acids in tissue lipids as measure of essential fatty acid requirement. J Nutr 70:405-410
23. Keen C, Olin AC, Edentoft A, Gronowitz E, Strandvik B 2007 Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, pseudomonas infection, and polyunsaturated fatty acids. Chest 131:1857-1864 (Pubitemid 46981646)
24. Van Biervliet S, Devos M, Delhaye T, Van Biervliet JP, Robberecht E, Christophe A 2008 Oral DHA supplementation in δF508 homozygous cystic fibrosis patients. Prostaglandins Leukot Essent Fatty Acids 78:109-115 (Pubitemid 351318229)
25. Cawood AL, Carroll MP, Wootton SA, Calder PC 2005 Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr Opin Clin Nutr Metab Care 8:153-159
26. Asayama K, Sandhir R, Sheikh FG, Hayashibe H, Nakane T, Singh I 1999 Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver. Mol Cell Biochem 194:227-234 (Pubitemid 29245563)
27. Bradbury NA, Jilling T, Berta G, Sorscher EJ, Bridges RJ, Kirk KL 1992 Regulation of plasma membrane recycling by CFTR. Science 256:530-532
28. Al-Turkmani MR, Andersson C, Alturkmani R, Katrangi W, Cluette-Brown JE, Freedman SD, Laposata M 2008 A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA. J Lipid Res 49:1946-1954
29. Kang JX, Man SF, Brown NE, Labrecque PA, Clandinin MT 1992 The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells. Biochem J 285:725-729
30. Andersson C, Al-Turkmani MR, Savaille JE, Alturkmani R, Katrangi W, CluetteBrown JE, Zaman MM, Laposata M, Freedman SD 2008 Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J Lipid Res 49:1692-1700
31. Zamaria N 2004 Alteration of polyunsaturated fatty acids status and metabolism in health and disease. Reprod Nutr Dev 44:273-282 (Pubitemid 39198969)
32. van Dorp D, Beerthuis RK, Nugteren DH, Vonkeman H 1964 The biosynthesis of prostaglandins. Biochim Biophys Acta 90:204-207
33. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG 1999 A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr (-/-) mice. Proc Natl Acad Sci USA 96:13995-14000
34. Strandvik B, Svensson E, Seyberth HW 1996 Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 55:419-425 (Pubitemid 27014130)
35. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF 2001 The essentiality of long chain n-3 fatty acid in relation to development and function of the brain and retina. Prog Lipid Res 40:1-94 (Pubitemid 32008650)
36. Dijck-Brouwer DA, Hadders-Algra M, Bouwstra H, Decsi T, Boehm G, Martini IA, Boersma ER, Muskiet FA 2005 Lower fetal status of docosahexaenoic acid, arachidonic acid and essential fatty acids is associated with less favourable neonatal neurological condition. Prostaglandins Leukot Essent Fatty Acids 72:21-28 (Pubitemid 39626784)
37. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN 2003 Novel docosatrienes and 17S-resolvins generated from dosahexanoic acid in murine brain, human blood and glial cells: autocoids in anti-inflammation. J Biol Chem 278:14677-14687 (Pubitemid 36799790)
38. Mukherjee PK, Marchesselli VL, Serhan CN, Bazan NG 2004 Neuroprotein Dl: a docohexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101:8491-8496
39. Borowitz D, Baker RD, Stellings V 2002 Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 35:246-259
40. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkomp G, Heijerman HG, Robberecht E, Döring G 2002 Nutrition in patients with cystic fibrosis: a European consensus. J Cyst Fibros 1:51-75
41. Henderson WR, Astley SJ, McCready MM, Kushmerick P, Casey S, Becker JW, Ramsey BW 1994 Oral absorption of omega 3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J Pediatr 124:400-408 (Pubitemid 24094450)
42. Pacetti D, Malavolta M, Bocci F, Boselli E, Frega NG 2004 High-performance liquid chromatography/electrospray ionization ion-trap tandem mass spectrometric analysis and quantification, of phosphatidylcholine molecular species in the serum of cystic fibrosis subjects supplemented with docosahexaenoic acid. Rapid Commun Mass Spectrom 18:2395-2400 (Pubitemid 39361779)
43. McKarney C, Everard ML, N'Diaye T 2007 Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev 4:CD002201 (Pubitemid 351805321)